Siemens Healthineers AG

SEMHF · Other OTC · USD

47,31USD

−1,26 (−2,60 %)Stand 11. Nov., 18:59

Vortag 48,57

Kennzahlen

Eröffnung
48,36
Vortag
48,57
Tagesspanne
47,31 – 48,36
52 Wochen
37,00 – 56,39
Volumen
384
Ø Volumen
3481
Börsenwert
52,95 Mrd. $
KGV
22,0
Gewinn je Aktie (TTM)
1,97
Dividendenrendite
2,3 %
Beta
0,8
Nächste Zahlen
4. Feb. 2027

Finanzen

EURFY 2026FY 2025FY 2024FY 2023FY 2022
Umsatz23,63 Mrd.23,42 Mrd.22,36 Mrd.21,68 Mrd.21,71 Mrd.
Herstellungskosten14,52 Mrd.14,37 Mrd.13,9 Mrd.13,97 Mrd.13,58 Mrd.
Bruttogewinn9,11 Mrd.9,05 Mrd.8,47 Mrd.7,71 Mrd.8,14 Mrd.
Forschung und Entwicklung1,97 Mrd.1,96 Mrd.1,92 Mrd.1,87 Mrd.1,79 Mrd.
Vertrieb und Verwaltung3,97 Mrd.3,64 Mrd.3,25 Mrd.3,4 Mrd.3,29 Mrd.
Operatives Ergebnis3,19 Mrd.3,44 Mrd.3,3 Mrd.2,44 Mrd.3,06 Mrd.
EBITDA4,49 Mrd.4,59 Mrd.4,22 Mrd.3,78 Mrd.4,26 Mrd.
Nettogewinn2,21 Mrd.2,15 Mrd.1,94 Mrd.1,51 Mrd.2,04 Mrd.
Gewinn je Aktie (verwässert)1,971,911,731,341,81

Bewertung

Letzte 12 Monate

KGV
22,0
Kurs-Umsatz-Verhältnis
2,1
Kurs-Buchwert-Verhältnis
2,4
PEG
6,0
Bruttomarge
38,6 %
Operative Marge
14,2 %
Nettomarge
9,4 %
Verschuldungsgrad
0,7
EV/EBITDA
13,5
Eigenkapitalrendite
11,7 %
Kapitalrendite (ROIC)
7,1 %
Free-Cashflow-Rendite
4,6 %
FY 2026FY 2025FY 2024FY 2023FY 2022
Bruttomarge38,6 %38,6 %37,9 %35,6 %37,5 %
Operative Marge13,5 %14,7 %14,8 %11,3 %14,1 %
Nettomarge9,4 %9,2 %8,7 %7,0 %9,4 %
KGV19,923,428,635,822,8
Kurs-Umsatz-Verhältnis1,92,12,52,52,1
Kurs-Buchwert-Verhältnis2,22,43,13,02,4
Verschuldungsgrad0,00,00,90,90,8
Liquidität 3. Grades1,21,11,21,11,1
Dividendenrendite2,5 %2,1 %1,9 %2,0 %2,0 %
Unternehmenswert41,61 Mrd.48,91 Mrd.69,15 Mrd.69,05 Mrd.61,86 Mrd.
EV/EBITDA9,310,616,418,314,5
Eigenkapitalrendite11,2 %10,1 %10,7 %8,3 %10,3 %
Kapitalrendite (ROIC)7,4 %6,4 %6,9 %5,1 %5,6 %
Free-Cashflow-Rendite5,5 %4,5 %3,2 %1,8 %3,0 %

Wachstum

FY 2026FY 2025FY 2024FY 2023FY 2022
Umsatz+0,9 %+4,7 %+3,2 %−0,2 %+20,7 %
Bruttogewinn+0,7 %+6,8 %+9,8 %−5,3 %+17,0 %
Operatives Ergebnis−7,2 %+4,3 %+35,2 %−20,4 %+10,3 %
Nettogewinn+3,1 %+10,6 %+28,7 %−26,0 %+18,0 %
Gewinn je Aktie+3,1 %+10,4 %+29,1 %−26,0 %+16,0 %
Freier Cashflow+7,8 %+28,0 %+82,6 %−30,8 %−33,4 %
Dividende je Aktie+4,8 %+0,1 %+0,0 %+12,0 %+9,3 %

Analysten

Einstufungen · Hold

  • 0Stark kaufen
  • 0Kaufen
  • 1Halten
  • 0Verkaufen
  • 0Stark verkaufen

Kursziel

Gerade nicht verfügbar.

Schätzungen

FY 2027FY 2028FY 2029
Umsatz (Ø)25,16 Mrd.26,68 Mrd.28,23 Mrd.
Umsatz (Tief – Hoch)23,94 Mrd. – 25,84 Mrd.25,49 Mrd. – 27,47 Mrd.26,91 Mrd. – 29,03 Mrd.
Gewinn je Aktie (Ø)2,372,672,96
Gewinn je Aktie (Tief – Hoch)2,22 – 2,452,51 – 2,772,78 – 3,07
Analysten111

Quartalszahlen

Nächste Zahlen: 4. Feb. 2027
Nov. 2026Juli 2026Mai 2026Feb. 2026Nov. 2025Juli 2025Mai 2025Feb. 2025
Gewinn je Aktie · Erwartet0,760,600,580,520,810,630,610,49
Gewinn je Aktie · Tatsächlich0,780,800,610,580,620,580,520,43
Abweichung+2,89 %+32,28 %+4,97 %+9,92 %−23,54 %−7,68 %−15,99 %−10,77 %
Umsatz · Tatsächlich7,69 Mrd.6,58 Mrd.6,56 Mrd.6,34 Mrd.10,38 Mrd.6,67 Mrd.6,48 Mrd.5,68 Mrd.

Dividenden und Splits

Ex-TagZahltagBetrag
9. Feb. 202610. Feb. 20261,19
20. Feb. 202521. Feb. 20251,00
19. Apr. 202423. Apr. 20241,01
16. Feb. 202320. Feb. 20231,01
16. Feb. 202218. Feb. 20220,97
15. Feb. 202117. Feb. 20210,80
13. Feb. 202017. Feb. 20200,87
6. Feb. 20198. Feb. 20190,80

Aktiensplits

–

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

–

Vergleichbare Unternehmen

Über das Unternehmen

Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide. The company's operations are structured into four distinct divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging division specializes in advanced medical imaging technologies, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray equipment, molecular imaging techniques, and ultrasound systems. Within the Diagnostics division, the focus is on supplying in-vitro diagnostic solutions and services to healthcare professionals across various settings, including laboratory, molecular, and point-of-care environments. It also delivers laboratory workflow optimization tools and informatics solutions. The Varian segment is dedicated to oncology, furnishing cancer care technologies, comprehensive solutions, and support services to hospital and clinic oncology departments. This includes advanced workflow optimization through technology, expert clinical services and consultancy, as well as digital tools and applications designed to streamline and oversee patient treatment and therapy protocols. The Advanced Therapies division delivers products engineered to facilitate image-guided, minimally invasive procedures in fields such as cardiology, interventional radiology, and surgery. Its offerings extend to angiography systems and mobile C-arms, notably featuring a robotic-assisted platform for endovascular interventions involving coronary and peripheral vasculature. Beyond these core segments, Siemens Healthineers also offers a suite of supplementary services. These comprise managing equipment performance, clinical training and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare institutions, alongside consulting and digital health solutions. Headquartered in Erlangen, Germany, Siemens Healthineers AG functions as a subsidiary of Siemens Aktiengesellschaft.

Führung

  • Bernhard MontagPresident, Chief Executive Officer & Chairman of Management Board
  • Jochen SchmitzChief Financial Officer & Member of Management Board
  • Darleen CaronChief Human Resources Officer, Labor Director & Member of Management Board
  • Elisabeth StaudingerMember of Management Board
  • Astrid Kristine PlossMember of Supervisory Board, Head of Legal Advanced Therapies & Head of Legal Technology Excellence
  • Arthur KaindlHead of Varian
CEO
Bernhard Montag
Mitarbeitende
74.600
Hauptsitz
Forchheim, BV, DE
Sektor
Healthcare
Branche
Medical - Devices
Börsengang
4. Aug. 2023

Nachrichten

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.